Announced
Financials
Sources
Tags
Public
Friendly
Acquisition
Private Equity
Minority
Pending
Single Bidder
Cross Border
Hong Kong
Pharmaceuticals
biopharmaceuticals
Synopsis
Canada Pension Plan Investment Board, a global investment management organization, is set to invest $100m in Chi-Med, a developer, manufacturer, and distributor pharmaceutical products. “This placement aligns with CPP Investments’ focus on providing strategic, long-term capital to industry leading companies where we can participate in the future success of the business and help create greater value through ongoing partnership. We look forward to supporting Chi-Med’s work on innovation in oncology treatment," Agus Tandiono, CPPIB Managing Director and Head of Fundamental Equities Asia.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.